Pillstats
Rx only · Solution · Oral

Escitalopram

Escitalopram Oxalate

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06AB10
RxCUI (US)321988
US makers2 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.055$0.110$0.165$0.219Dec 2025Apr 2026Jul 2026
$0.139
Latest avg · Jul 22, 2026
-24%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.6K5.1K7.7K10K2025 Q12025 Q22025 Q32025 Q42026 Q1
8.7K
Rx · 2026 Q1
2.8M
Units dispensed
+20%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Macleods Pharmaceuticals Limitedunknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.